Found: 14
Select item for more details and to access through your institution.
First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 302, doi. 10.1002/ajh.26068
- By:
- Publication type:
- Article
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. E24, doi. 10.1002/ajh.24951
- By:
- Publication type:
- Article
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. E166, doi. 10.1002/ajh.24773
- By:
- Publication type:
- Article
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 511, doi. 10.1002/ajh.23999
- By:
- Publication type:
- Article
Late-Onset Progressive Multifocal Leukoencephalopathy (PML) and Lymphoma in a 65-Year-Old Patient with XIAP Deficiency.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy.
- Published in:
- Journal of Clinical Immunology, 2012, v. 32, n. 3, p. 632, doi. 10.1007/s10875-011-9624-5
- By:
- Publication type:
- Article
Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 4, p. 1, doi. 10.1007/s11912-017-0581-x
- By:
- Publication type:
- Article
True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1047, doi. 10.1046/j.1365-2141.2001.02841.x
- By:
- Publication type:
- Article
A role for HVEM, but not lymphotoxin-β receptor, in LIGHT-induced tumor cell death and chemokine production.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 9, p. 2502, doi. 10.1002/eji.200939069
- By:
- Publication type:
- Article
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51264-2
- By:
- Publication type:
- Article
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3-L.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 357, doi. 10.1046/j.1365-2141.1999.01582.x
- By:
- Publication type:
- Article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
- By:
- Publication type:
- Article
Patients’ Non-Medical Characteristics Contribute to Collective Medical Decision-Making at Multidisciplinary Oncological Team Meetings.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0154969
- By:
- Publication type:
- Article